What is she best known for?
The fields of study she is best known for:
- Immune system
- Cancer
- Gene
The scientist’s investigation covers issues in Immunology, Antigen, Immune system, Epitope and T cell.
Her Immunology study integrates concerns from other disciplines, such as Cancer research and Pancreatic cancer.
Her Antigen study incorporates themes from Cancer, Cytotoxic T cell, Tumor antigen and Antibody.
Olivera J. Finn has researched Cancer in several fields, including Translational research and Computational biology.
Her work carried out in the field of Epitope brings together such families of science as Molecular biology, Mucin, Monoclonal antibody and Adenocarcinoma.
The various areas that Olivera J. Finn examines in her T cell study include Acquired immune system and Immunogenicity.
Her most cited work include:
- The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research (957 citations)
- Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of t-cell function in advanced cancer patients. (707 citations)
- Cancer vaccines: between the idea and the reality. (516 citations)
What are the main themes of her work throughout her whole career to date?
Immunology, Antigen, Cancer, Immune system and MUC1 are her primary areas of study.
Her studies in Immunology integrate themes in fields like Cytotoxic T cell and Cancer research.
Her Cytotoxic T cell research incorporates themes from CD8 and Major histocompatibility complex.
Her study explores the link between Antigen and topics such as Molecular biology that cross with problems in CTL*.
Her Cancer study deals with the bigger picture of Internal medicine.
Her Immune system study combines topics from a wide range of disciplines, such as Adjuvant, Disease and Vaccination.
She most often published in these fields:
- Immunology (48.36%)
- Antigen (35.66%)
- Cancer (28.28%)
What were the highlights of her more recent work (between 2013-2021)?
- Immunology (48.36%)
- Cancer (28.28%)
- Antigen (35.66%)
In recent papers she was focusing on the following fields of study:
Her scientific interests lie mostly in Immunology, Cancer, Antigen, Immune system and MUC1.
Cancer vaccine, T cell and Vaccination are among the areas of Immunology where Olivera J. Finn concentrates her study.
Her work on Immunotherapy and Cancer prevention is typically connected to Myeloid-derived Suppressor Cell as part of general Cancer study, connecting several disciplines of science.
Her Antigen research incorporates elements of Antibody, Gene, Tumor antigen and Virology.
Her research in the fields of Immunosurveillance, Immunity and Autoimmunity overlaps with other disciplines such as Glycopeptide.
Her study in MUC1 is interdisciplinary in nature, drawing from both Gastroenterology, Metastasis and Disease.
Between 2013 and 2021, her most popular works were:
- The dawn of vaccines for cancer prevention (74 citations)
- Precancer Atlas to Drive Precision Prevention Trials (69 citations)
- Current modalities in cancer immunotherapy: Immunomodulatory antibodies, CARs and vaccines☆ (56 citations)
In her most recent research, the most cited papers focused on:
- Immune system
- Cancer
- Gene
Olivera J. Finn focuses on Antigen, Cancer, Immune system, Immunosurveillance and Immunology.
Her Antigen research is multidisciplinary, incorporating perspectives in Antibody and Tumor antigen.
Her Cancer study often links to related topics such as Cancer research.
Her studies deal with areas such as Virus and Gene as well as Immune system.
Her work deals with themes such as T cell and Pancreatic cancer, which intersect with Immunosurveillance.
While the research belongs to areas of Immunology, Olivera J. Finn spends her time largely on the problem of Cancer prevention, intersecting her research to questions surrounding Normal tissue and Disease.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
